Award notice
Tactical Injector Kit - Ketamine
FA238424CB013
Department of the Air Force, FA2384 USAF AFMC AFRL PZL AFRL Rakh. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Awarded
$12,334,570.00 on the award notice, September 24, 2024, contract FA238424CB013
Description
As published on SAM.gov.
Rx Bandz Inc., Austin, Texas, was awarded a $12,334,570 cost-plus-fixed-fee SBIR Phase III contract for tactical injection kit development. This contract provides for the development of an FDA-approved auto-injector device that can deliver a pre-measured dose of ketamine for mild sedation at point of injury in austere environments and/or during patient transport. Work will be performed in Fairfield, New Jersey, and is expected to be completed by Oct. 1, 2029.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- RX Bandz, Inc.
- UEI
- DXRED7S6FVE9
- CAGE
- 7N2K8
- Vendor location
- Austin, TX
- Contract
- FA238424CB013, definitive contract
- Obligated
- $6,516,908.00, current value $12,334,570
- Actions
- 8 between September 24, 2024 and May 28, 2026
- Competition
- Full and Open Competition After Exclusion of Sources, 273 offers received
- Set-aside reported
- Small Business Set Aside - Total
- Described as
- Tactical Injector Kit - Ketamine
- Match
- award number FA238424CB013 equals the contract number; same awarding office FA2384 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 24, 2024
Award notice
Awarded to RX BANDZ, Inc. Austin for $12,334,570. SAM.gov, notice dfdf3429c48d4329b6a56ea6919a6807
Points of contact
- Amber Tayloramber.taylor.9@us.af.mil